Clinical Trials Browser

Phase 4 × Withdrawn × Delirium × Clear all

NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders